Loss of functional GABA A receptors in the Alzheimer diseased brain

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 25, 2012, Pages 10071-10076

  Limon, Agenor ^a   Reyes Ruiz, Jorge Mauricio ^a   Miledi, Ricardo ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gephyrin; Glutamate receptor; Neurodegeneration; Synaptic mechanism

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA2; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA5; 4 AMINOBUTYRIC ACID A RECEPTOR BETA2; 4 AMINOBUTYRIC ACID A RECEPTOR BETA3; 4 AMINOBUTYRIC ACID A RECEPTOR GAMMA2; BENZODIAZEPINE; GEPHYRIN; GLUTAMATE RECEPTOR; MESSENGER RNA; VOLTAGE DEPENDENT ANION CHANNEL;

AGING; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CHOLINERGIC TRANSMISSION; DESENSITIZATION; GABAERGIC TRANSMISSION; NERVE CELL MEMBRANE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNAPTIC TRANSMISSION; TEMPORAL CORTEX; XENOPUS;

AGING; ALZHEIMER DISEASE; BRAIN; CASE-CONTROL STUDIES; DOWN-REGULATION; HUMANS; RECEPTORS, GABA-A;

EID: 84862560975     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1204606109     Document Type: Article

References (46)

1. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298:789-791.
2. Rissman RA, Mobley WC (2011) Implications for treatment: GABAA receptors in aging, Down syndrome and Alzheimer's disease. J Neurochem 117:613-622.
3. Luchetti S, Huitinga I, Swaab DF (2011) Neurosteroid andGABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis. Neuroscience 191:6-21.
4. Olsen RW, Sieghart W (2008) International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: Classification on the basis of subunit composition, pharmacology, and function. Update. Pharmacol Rev 60:243-260.
5. Lanctôt KL, Herrmann N, Mazzotta P, Khan LR, Ingber N (2004) GABAergic function in Alzheimer's disease: Evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia. Can J Psychiatry 49:439-453.
6. McEnery MW (1992) The mitochondrial benzodiazepine receptor: Evidence for association with the voltage-dependent anion channel (VDAC). J Bioenerg Biomembr 24:63-69.
7. Scarf AM, Ittner LM, Kassiou M (2009) The translocator protein (18 kDa): central nervous system disease and drug design. J Med Chem 52:581-592.
8. Cosenza-Nashat M, et al. (2009) Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain. Neuropathol Appl Neurobiol 35:306-328.
9. Mizukami K, Grayson DR, Ikonomovic MD, Sheffield R, Armstrong DM (1998) GABAA receptor β 2 and β 3 subunits mRNA in the hippocampal formation of aged human brain with Alzheimer-related neuropathology. Brain Res Mol Brain Res 56:268-272.
10. Miledi R, Dueñas Z, Martinez-Torres A, Kawas CH, Eusebi F (2004) Microtransplantation of functional receptors and channels from the Alzheimer's brain to frog oocytes. Proc Natl Acad Sci USA 101:1760-1763.
11. Bernareggi A, Dueñas Z, Reyes-Ruiz JM, Ruzzier F, Miledi R (2007) Properties of glutamate receptors of Alzheimer's disease brain transplanted to frog oocytes. Proc Natl Acad Sci USA 104:2956-2960.
12. Pennisi G, et al. (2002) Motor cortex excitability in Alzheimer disease: One year follow-up study. Neurosci Lett 329:293-296.
13. Di Lazzaro V, et al. (2004) Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease. J Neurol Neurosurg Psychiatry 75:555-559.
14. Marcade M, et al. (2008) Etazolate, a neuroprotective drug linking GABA(A) receptor pharmacology to amyloid precursor protein processing. J Neurochem 106:392-404.
15. Fritschy JM, Harvey RJ, Schwarz G (2008) Gephyrin: Where do we stand, where do we go? Trends Neurosci 31:257-264.
16. Jesse S, et al. (2009) Glial fibrillary acidic protein and protein S-100B: Different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer's disease and Creutzfeldt-Jakob disease. J Alzheimers Dis 17:541-551.
17. Russek SJ (1999) Evolution of GABA(A) receptor diversity in the human genome. Gene 227:213-222.
18. Whiting PJ, et al. (1999) Molecular and functional diversity of the expanding GABA-A receptor gene family. Ann N Y Acad Sci 868:645-653.
19. Roden WH, Peugh LD, Jansen LA (2010) Altered GABA(A) receptor subunit expression and pharmacology in human Angelman syndrome cortex. Neurosci Lett 483:167-172.
20. Armstrong DM, Ikonomovic MD, Sheffield R, Wenthold RJ (1994) AMPA-selective glutamate receptor subtype immunoreactivity in the entorhinal cortex of non-demented elderly and patients with Alzheimer's disease. Brain Res 639:207-216.
21. Gong Y, Lippa CF, Zhu J, Lin Q, Rosso AL (2009) Disruption of glutamate receptors at Shank-postsynaptic platform in Alzheimer's disease. Brain Res 1292:191-198.
22. Partin KM, Patneau DK, Winters CA, Mayer ML, Buonanno A (1993) Selective modulation of desensitization at AMPA versus kainate receptors by cyclothiazide and concanavalin A. Neuron 11:1069-1082.
23. Palma E, et al. (2004) Phosphatase inhibitors remove the run-down of gamma-aminobutyric acid type A receptors in the human epileptic brain. Proc Natl Acad Sci USA 101:10183-10188.
24. Barish ME (1983) A transient calcium-dependent chloride current in the immature Xenopus oocyte. J Physiol 342:309-325.
25. Thompson SA, et al. (2004) Salicylidene salicylhydrazide, a selective inhibitor of beta 1-containing GABAA receptors. Br J Pharmacol 142:97-106.
26. Allen SJ, et al. (1983) Biochemical evidence of selective nerve cell changes in the normal ageing human and rat brain. J Neurochem 41:256-265.
27. Owen F, Poulter M, Waddington JL, Mashal RD, Crow TJ (1983) [3H]R05-4864 and [3H]flunitrazepam binding in kainate-lesioned rat striatum and in temporal cortex of brains from patients with senile dementia of the Alzheimer type. Brain Res 278:373-375.
28. Coleman PD, Flood DG (1987) Neuron numbers and dendritic extent in normal aging and Alzheimer's disease. Neurobiol Aging 8:521-545.
29. Hof PR, Morrison JH (2004) The aging brain: Morphomolecular senescence of cortical circuits. Trends Neurosci 27:607-613.
30. Dickstein DL, et al. (2007) Changes in the structural complexity of the aged brain. Aging Cell 6:275-284.
31. Loerch PM, et al. (2008) Evolution of the aging brain transcriptome and synaptic regulation. PLoS ONE 3:e3329.
32. Sherwood CC, et al. (2011) Aging of the cerebral cortex differs between humans and chimpanzees. Proc Natl Acad Sci USA 108:13029-13034.
33. Rabinovici GD, et al. (2010) Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain 133:512-528.
34. Marshall GA, Fairbanks LA, Tekin S, Vinters HV, Cummings JL (2007) Early-onset Alzheimer's disease is associated with greater pathologic burden. J Geriatr Psychiatry Neurol 20:29-33.
35. Garcia-Marin V, et al. (2009) Diminished perisomatic GABAergic terminals on cortical neurons adjacent to amyloid plaques. Front Neuroanat 3:28.
36. Iwakiri M, et al. (2009) An immunohistochemical study of GABAA receptor gamma subunits in Alzheimer's disease hippocampus: Relationship to neurofibrillary tangle progression. Neuropathology 29:263-269.
37. Agarwal S, Tannenberg RK, Dodd PR (2008) Reduced expression of the inhibitory synapse scaffolding protein gephyrin in Alzheimer's disease. J Alzheimers Dis 14:313-321.
38. Fraser DD, et al. (1995) GABAA/benzodiazepine receptors in acutely isolated hippocampal astrocytes. J Neurosci 15:2720-2732.
39. Bonnert TP, et al. (1999) θ, a novel gamma-aminobutyric acid type A receptor subunit. Proc Natl Acad Sci USA 96:9891-9896.
40. Huntsman MM, Huguenard JR (2006) Fast IPSCs in rat thalamic reticular nucleus require the GABAA receptor beta1 subunit. J Physiol 572:459-475.
41. Khom S, et al. (2006) Pharmacological properties of GABAA receptors containing gamma1 subunits. Mol Pharmacol 69:640-649.
42. Gallacher J, et al. (2011) Benzodiazepine use and risk of dementia: Evidence from the Caerphilly Prospective Study (CaPS). J Epidemiol Community Health, 10.1136/jech-2011-200314.
43. Liepert J, Bär KJ, Meske U, Weiller C (2001) Motor cortex disinhibition in Alzheimer's disease. Clin Neurophysiol 112:1436-1441.
44. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Δ Δ C(T)) Method. Methods 25:402-408.
45. Yuan JS, Reed A, Chen F, Stewart CN, Jr. (2006) Statistical analysis of real-time PCR data. BMC Bioinformatics 7:85.
46. Limon A, Reyes-Ruiz JM, Miledi R (2008) Microtransplantation of neurotransmitter receptors from postmortem autistic brains to Xenopus oocytes. Proc Natl Acad Sci USA 105:10973-10977.